文献速递慢性肾脏病

PREDICT工具预测妊娠相关CKD进展

PREDICT Tool for Pregnancy-Associated CKD Progression.
PubMed 文献 · Kidney Int Rep · 2026-06-06

该研究开发并外部验证了2个预测模型,用于预测CKD女性妊娠后肾脏和新生儿不良结局。主要结局为产后12个月内eGFR下降≥25%或需要肾脏替代治疗(KRT),次要结局为小于胎龄儿(SGA)和/或早产(<34周)。模型在外部验证中显示出高敏感性和阴性预测值。

要点

  • PREDICT模型可个体化预测CKD女性妊娠后肾脏和新生儿不良结局风险。
  • 主要结局预测阈值0.15时敏感性90%、NPV 85%;次要结局阈值0.10时敏感性90%、NPV 80%。
  • 该工具可辅助临床咨询和共同决策。

核心结论

  • 开发并验证了高性能模型,可预测CKD女性妊娠后共同选择的不良肾脏和新生儿结局。

研究设计与样本

  • 开发队列来自RaDar、UKRR和HES链接数据,纳入746名preconception 24个月内eGFR<90 ml/min/1.73 m2且1997-2021年分娩的女性。
  • 外部验证队列包括加拿大Ontario妊娠队列(2007-2022,n=6974)和3项英国妊娠CKD研究(2010-2018,n=380)。

主要发现

  • 开发队列中位prepregnancy eGFR为58 ml/min/1.73 m2。
  • 主要结局最佳截断点0.15(敏感性90%,NPV 85%),次要结局0.10(敏感性90%,NPV 80%)。
  • 外部验证显示主要结局具有高敏感性和NPV。
  • KFRE 2年预测风险中位数1.4%,低于PREDICT模型1年预测的48%,但终点不同限制可比性。

关键数值与推荐

  • 主要结局:产后12个月内eGFR下降≥25%或KRT;次要结局:SGA(<3rd百分位)和/或早产(<34周)。
  • 预测概率≥0.15提示主要结局高风险,≥0.10提示次要结局高风险。

临床怎么用

  • 可用于CKD女性孕前咨询,个体化评估妊娠后肾脏和新生儿不良结局风险。
  • 模型输出风险概率可辅助患者和医疗专业人员共同决策。

局限性

  • 与KFRE比较受限于不同终点定义。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Prepregnancy counselling is recommended for women with chronic kidney disease (CKD) to discuss potential adverse outcomes; however, no tools exist to estimate individual risk. We aimed to develop and externally validate 2 prediction models for outcomes prioritized by people with CKD and health care professionals: The primary outcome was the probability of ≥25% reduction in estimated glomerular filtration rate (eGFR) or kidney replacement therapy (KRT) within 12 months postpartum. The secondary outcome was the probability of small-for-gestational-age (SGA) (< 3rd percentile) infant and/or preterm delivery (< 34 weeks). METHODS: The development cohort used linked data from the National Registry of Rare Kidney Disease (RaDar), UK Renal Registry (UKRR) and NHS Hospital Episode Statistics (HES). Individuals with eGFR < 90 ml/min per 1.73 m2 within 24 months preconception and deliveries between 1997 and 2021 were included. Validation cohorts were as follows: (i) Ontario Pregnancy Cohort (2007-2022) and (ii) 3 UK pregnancy-CKD studies (2010-2018). Candidate predictors were selected from known risk factors. Clinically relevant cut-points were determined with people with CKD. RESULTS: The development cohort included 746 women (median prepregnancy eGFR: 58 ml/min per 1.73 m2); validation cohorts included 6974 and 380 women. Optimal cut-points of 0.15 (sensitivity: 90%, negative predictive value (NPV): 85%) and 0.10 (sensitivity: 90%, NPV: 80%) were selected for the primary and secondary outcomes. External validations demonstrated high sensitivity and NPV for the primary outcome. Although comparability is limited by differing end points, Kidney Failure Risk Equation (KFRE) predictions (2-year) were lower than our PREDICT model (1-year) (median risk 1.4% vs. 48%). CONCLUSION: We developed high performing models for individuals with CKD to predict coselected adverse kidney and neonatal outcomes from contemporaneous cohorts. Individualized pregnancy risk assessment tools could support future parents and health care professionals to make informed choices.

来源:Kidney Int Rep,查看原文。版权归原作者所有。

引用

  1. Ralston E, Hamill M, Santhakumaran S, et al. PREDICT Tool for Pregnancy-Associated CKD Progression. Kidney Int Rep. 2026. PMID: 42438723. doi:10.1016/j.ekir.2026.106636

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。